Drug R&D

Scientific and technological innovation is the first productive force. We should adhere to the market demand as the core, and build a full-chain innovation system from "0" to "1" (basic research) from "1" to "100" (industrial innovation).

R&D Center

Harway (Jinan) Pharmaceutical Technology Co., Ltd
Dongying Shandong Harway Pharmaceutical Research Institute Co., Ltd

Five technical platforms

Innovative drug pilot scale-up technology platform; Technical platform for consistency evaluation of generic drugs; API registration and application technology platform; The marketing license entrusts the production of CDMO technology platform; The technical platform for the preparation of classic and famous traditional Chinese medicines.

Four Core Teams

Continuous response technical team

Develop micro-channel, tubular and other continuous reaction equipment, create a safe and efficient operation mode, quickly build reactors, screen reaction conditions and implement project production

Enzyme-catalyzed green reaction technology team

Deeply cultivate multi-chiral and highly difficult biocatalytic products and high-value-added biosynthetic products, and build a technical team of "enzyme catalysis+chemical synthesis, biosynthesis+biological transformation"

Safety assessment technical team

Build a process safety assessment technology platform, build and improve the safety assessment process, and identify potential risks in the process

Green closed-loop industrialization technical team

Reduce the total amount of "three wastes" from the source, develop "green closed-loop process", and establish a "green development" technical team

  • Tel:0546-5057288
  • E-mail:kjb@harwaypharma.com
  • Back to top